Adaptive radiotherapy for locally advanced non-small cell lung cancer: dosimetric gain and treatment outcome prediction.

The article discusses a study focusing on the use of adaptive radiotherapy for treating locally advanced non-small cell lung cancer (NSCLC). Topics discussed include the outcomes of concurrent chemoradiotherapy (cCRT) for the NSCLC, the use of 18F-fludeoxyglucose–positron emission tomography or computed tomography during therapy, and the complication from the underdosage of microscopic disease (MD).